Literature DB >> 23466198

Open tubular columns containing the immobilized ligand binding domain of peroxisome proliferator-activated receptors α and γ for dual agonists characterization by frontal affinity chromatography with mass spectrometry detection.

C Temporini1, G Pochetti, G Fracchiolla, L Piemontese, R Montanari, R Moaddel, A Laghezza, F Altieri, L Cervoni, D Ubiali, E Prada, F Loiodice, G Massolini, E Calleri.   

Abstract

The peroxisome proliferator-activated receptors (PPARs) belong to the nuclear receptor superfamily. In the last years novel PPARs ligands have been identified and these include PPARα/γ dual agonists. To rapidly identify novel PPARs dual ligands, a robust binding assay amenable to high-throughput screening toward PPAR isoforms would be desirable. In this work we describe a parallel assay based on the principles of frontal affinity chromatography coupled to mass spectrometry (FAC-MS) that can be used to characterize dual agonists. For this purpose the ligand binding domain of PPARα receptor was immobilized onto the surface of open tubular capillaries to create new PPAR-alpha-OT columns to be used in parallel with PPAR-gamma-OT columns. The two biochromatographic systems were used in both ranking and Kd experiments toward new ureidofibrate-like dual agonists for subtype selectivity ratio determination. In order to validate the system, the Kd values determined by frontal analysis chromatography were compared to the affinity constants obtained by ITC experiments. The results of this study strongly demonstrate the specific nature of the interaction of the ligands with the two immobilized receptor subtypes.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23466198      PMCID: PMC3618287          DOI: 10.1016/j.chroma.2013.01.077

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  23 in total

Review 1.  Applications of isothermal titration calorimetry in pure and applied research--survey of the literature from 2010.

Authors:  Rajesh Ghai; Robert J Falconer; Brett M Collins
Journal:  J Mol Recognit       Date:  2012-01       Impact factor: 2.137

Review 2.  Frontal affinity chromatography in characterizing immobilized receptors.

Authors:  E Calleri; C Temporini; G Massolini
Journal:  J Pharm Biomed Anal       Date:  2010-12-02       Impact factor: 3.935

Review 3.  Affinity selection-mass spectrometry screening techniques for small molecule drug discovery.

Authors:  D Allen Annis; Elliot Nickbarg; Xianshu Yang; Michael R Ziebell; Charles E Whitehurst
Journal:  Curr Opin Chem Biol       Date:  2007-10-10       Impact factor: 8.822

4.  The synthesis and initial characterization of an immobilized purinergic receptor (P2Y1) liquid chromatography stationary phase for online screening.

Authors:  Ruin Moaddel; Enrica Calleri; Gabriella Massolini; Chester R Frazier; Irving W Wainer
Journal:  Anal Biochem       Date:  2007-02-22       Impact factor: 3.365

Review 5.  Target-based drug discovery: the emerging success of frontal affinity chromatography coupled to mass spectrometry.

Authors:  Enrica Calleri; Caterina Temporini; Gabriele Caccialanza; Gabriella Massolini
Journal:  ChemMedChem       Date:  2009-06       Impact factor: 3.466

Review 6.  The development and characterization of protein-based stationary phases for studying drug-protein and protein-protein interactions.

Authors:  Mitesh Sanghvi; Ruin Moaddel; Irving W Wainer
Journal:  J Chromatogr A       Date:  2011-05-27       Impact factor: 4.759

7.  Frontal affinity chromatography-mass spectrometry useful for characterization of new ligands for GPR17 receptor.

Authors:  Enrica Calleri; Stefania Ceruti; Gloria Cristalli; Claudia Martini; Caterina Temporini; Chiara Parravicini; Rosaria Volpini; Simona Daniele; Gabriele Caccialanza; Davide Lecca; Catia Lambertucci; Maria Letizia Trincavelli; Gabriella Marucci; Irving W Wainer; Graziella Ranghino; Piercarlo Fantucci; Maria P Abbracchio; Gabriella Massolini
Journal:  J Med Chem       Date:  2010-05-13       Impact factor: 7.446

8.  The preparation and development of cellular membrane affinity chromatography columns.

Authors:  Ruin Moaddel; Irving W Wainer
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

Review 9.  Risk of fractures with glitazones: a critical review of the evidence to date.

Authors:  Michael Bodmer; Christian Meier; Marius E Kraenzlin; Christoph R Meier
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

Review 10.  Recent developments in protein-ligand affinity mass spectrometry.

Authors:  Niels Jonker; Jeroen Kool; Hubertus Irth; Wilfried M A Niessen
Journal:  Anal Bioanal Chem       Date:  2010-11-08       Impact factor: 4.142

View more
  7 in total

1.  Resveratrol and its metabolites bind to PPARs.

Authors:  E Calleri; G Pochetti; K S S Dossou; A Laghezza; R Montanari; D Capelli; E Prada; F Loiodice; G Massolini; M Bernier; R Moaddel
Journal:  Chembiochem       Date:  2014-05-05       Impact factor: 3.164

Review 2.  Analysis of stereoselective drug interactions with serum proteins by high-performance affinity chromatography: A historical perspective.

Authors:  Zhao Li; David S Hage
Journal:  J Pharm Biomed Anal       Date:  2017-01-11       Impact factor: 3.935

3.  Development of enhanced capacity affinity microcolumns by using a hybrid of protein cross-linking/modification and immobilization.

Authors:  Xiwei Zheng; Maria Podariu; Cong Bi; David S Hage
Journal:  J Chromatogr A       Date:  2015-05-01       Impact factor: 4.759

Review 4.  Analysis of Biological Interactions by Affinity Chromatography: Clinical and Pharmaceutical Applications.

Authors:  David S Hage
Journal:  Clin Chem       Date:  2017-04-10       Impact factor: 8.327

Review 5.  Analysis of biomolecular interactions using affinity microcolumns: a review.

Authors:  Xiwei Zheng; Zhao Li; Sandya Beeram; Maria Podariu; Ryan Matsuda; Erika L Pfaunmiller; Christopher J White; NaTasha Carter; David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2014-01-27       Impact factor: 3.205

6.  New approaches for prevention and treatment of Alzheimer's disease: a fascinating challenge.

Authors:  Luca Piemontese
Journal:  Neural Regen Res       Date:  2017-03       Impact factor: 5.135

7.  Betulinic acid is a PPARγ antagonist that improves glucose uptake, promotes osteogenesis and inhibits adipogenesis.

Authors:  Gloria Brusotti; Roberta Montanari; Davide Capelli; Giulia Cattaneo; Antonio Laghezza; Paolo Tortorella; Fulvio Loiodice; Franck Peiretti; Bernadette Bonardo; Alessandro Paiardini; Enrica Calleri; Giorgio Pochetti
Journal:  Sci Rep       Date:  2017-07-18       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.